Hospital Medicine News

The national blood inventory is at its lowest level for this time of the year since 2015, according to the Red Cross.

Arkansas health officials reported COVID-19 case data during IDWeek that demonstrate the severe toll the delta variant has had on the state’s children.

A 3-day course of IV remdesivir was safe, well tolerated and prevented COVID-19-related hospitalizations among high-risk COVID-19 patients, according to data presented at IDWeek.

Molnupiravir, an investigational oral antiviral drug, significantly reduced the risk for hospitalization or death from COVID-19 among high-risk patients, according to a company press release.

Recent findings in The New England Journal of Medicine showed that AstraZeneca’s two-dose COVID-19 vaccine was 74% effective against symptomatic disease.

Unlike influenza and respiratory syncytial virus, which all but disappeared during their typical winter peaks, common cold viruses continued to circulate among children during the COVID-19 pandemic, according to researchers at IDWeek.

Safety monitoring found “no unexpected patterns of adverse reactions” among thousands of Americans who have received a third dose of a COVID-19 messenger RNA vaccine, researchers reported in MMWR.

A study published in JAMA Pediatrics linked exposure to gun violence to a rise in pediatric ED visits for mental health issues, especially for children who witnessed such actions.

The Moderna vaccine was found to be more effective than the Pfizer-BioNTech vaccine at preventing symptomatic COVID-19 in U.S. health care workers, according to findings published in The New England Journal of Medicine.

The Pfizer-BioNTech COVID-19 vaccine elicited “relatively lower” antibody levels in adults aged 50 years or older than in adults aged younger than 50 years, researchers reported in JAMA Network Open.